Copyright
©2009 The WJG Press and Baishideng. All rights reserved.
World J Gastroenterol. Jun 28, 2009; 15(24): 2960-2974
Published online Jun 28, 2009. doi: 10.3748/wjg.15.2960
Published online Jun 28, 2009. doi: 10.3748/wjg.15.2960
Systemic abnormalities in liver disease
Masami Minemura, Kazuto Tajiri, Department of Gastroenterology and Hematology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan
Yukihiro Shimizu, Department of Internal Medicine, Nanto Municipal Hospital, 938 Inami, Nanto 932-0211, Japan
Author contributions: Each author wrote one third of the manuscript; Shimizu Y designed and organized the entire manuscript.
Correspondence to: Yukihiro Shimizu, MD, PhD, Department of Internal Medicine, Nanto Municipal Hospital, 938 Inami, Nanto 932-0211, Japan. yukihiro@katsura.com
Telephone: +81-763-821475
Fax: +81-763-821853
Received: April 9, 2009
Revised: May 23, 2009
Accepted: May 30, 2009
Published online: June 28, 2009
Revised: May 23, 2009
Accepted: May 30, 2009
Published online: June 28, 2009
Abstract
Systemic abnormalities often occur in patients with liver disease. In particular, cardiopulmonary or renal diseases accompanied by advanced liver disease can be serious and may determine the quality of life and prognosis of patients. Therefore, both hepatologists and non-hepatologists should pay attention to such abnormalities in the management of patients with liver diseases.
Keywords: Systemic abnormality, Risk of surgery, Drug dosage, Liver disease